Endovascular Management of a Left Subclavian Artery Lesion Following Thoracoplasty for Bronchopleural Fistula and Empyema Secondary to Aspergillus fumigatus

Ramos, Ricard; Rodríguez, Laura; Saumench, Josep; Iborra, Elena; Cairols, Marc Antoni; Dorca, Jordi

doi:10.1016/S1579-2129(08)60055-5

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and translational research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 44. Issue 6.

Pages 338-340 (January 2008)

More article options

Pages 338-340 (January 2008)

Case Report

DOI: 10.1016/S1579-2129(08)60055-5

Full text access

Endovascular Management of a Left Subclavian Artery Lesion Following Thoracoplasty for Bronchopleural Fistula and Empyema Secondary to Aspergillus fumigatus

Visits

4170

Download PDF

Ricard Ramosa,

Corresponding author

ricardramos@ub.edu

Correspondence: Dr R. Ramos Servei de Cirurgia Toràcica, Hospital Universitari de Bellvitge Feixa Llarga, s/n08907 L'Hospitalet de Llobregat Barcelona, Spain

, Laura Rodríguezb, Josep Saumenchc, Elena Iborrab, Marc Antoni Cairolsb, Jordi Dorcad

a Unitat d'Anatomia i Embriologia Humana, Servei de Cirurgia Toràcica, Hospital Universitari de Bellvitge, Universidad de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain

b Servei d'Angiologia i Cirurgia Vascular, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain

c Servei de Cirurgia Toràcica, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain

d Servei de Pneumologia, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain

This item has received

4170 Visits

Article information

Statistics

Massive and/or recurrent hemoptysis is a clear indicationfor surgical treatment of pleuropulmonary aspergilloma, despitethe incidence of postoperative morbidity and mortality. Thoracoplasty has been widely used for 20 years and is stillindicated in these cases, following lobectomy, even though theprocedure is not free of complications. We report the case of a patient who required thoracoplasty to treat apleuropulmonary aspergilloma invading the chest wall. Subsequent placement of an aortic stent-graft was requireddue to tearing of the left subclavian artery.

Key words:

Pulmonary aspergilloma

Thoracoplasty

Thoracicaortic stent-graft

La hemoptisis masiva y/o repetitiva es una indicación cla-ra de tratamiento quirúrgico del aspergiloma pleuropulmo-nar, a pesar de la morbimortalidad posquirúrgica existente. La toracoplastia, muy utilizada hace 2 décadas, todavía tie-ne su indicación aquí, tras lobectomía, aunque no está exen-ta de complicaciones. Presentamos un caso de aspergilomapleuropulmonar con invasión de pared torácica que requi-rió toracoplastia y posteriormente técnicas endovascularesaórticas por desgarro de la arteria subclavia izquierda.

Palabras clave:

Aspergiloma pulmonar

Toracoplastia

Endoprótesisde aorta torácica

Full text is only aviable in PDF

References

[1]

MW Pound, RH Drew, JR Perfect.

Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia.

Curr Opin Infect Dis, 15 (2002), pp. 183-194

Medline

[2]

G Massard, N Roeslin, JM Wihlm, P Dumont, JP Witz, G Morand.

Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment.

Ann Thorac Surg, 54 (1992), pp. 1159-1164

Medline

[3]

G Babatasi, M Massetti, A Chapelier, E Fadel, P Machiarini, A Khayat, et al.

Surgical treatment of pulmonary aspergilloma: current outcome.

J Thorac Cardiovasc Surg, 119 (2000), pp. 906-912

http://dx.doi.org/10.1016/S0022-5223(00)70085-7 | Medline

[4]

British Tuberculosis and Thoracic Association.

Aspergilloma and residual tuberculous cavities: the results of a resurvey.

Tubercle, 41 (1970), pp. 227-245

[5]

OP Sharma, R Chwogule.

Many faces of pulmonary aspergillosis.

Eur Respir J, 12 (1998), pp. 705-715

Medline

[6]

C Díaz-Sánchez, A López-Viña.

Aspergillus y pulmón.

Arch Bronconeumol, 40 (2004), pp. 114-122

Medline

[7]

K Mori, Y Saida, K Kuramoto, I Anno, H Yoshioka, T Irie, et al.

Transcatheter embolization of mycotic aneurysm of the subclavian artery with metallic coils.

J Cardiovasc Surg (Torino), 41 (2000), pp. 463-467

[8]

T Waggershauser, K Herrmann, M Reiser.

Reconstructive endovascular treatment procedures in the area of the a. subclavia and its branches.

Radiologe, 40 (2000), pp. 821-825

Medline

[9]

DR Nathanson, JA Rodríguez-López, VG Ramaiah, J Williams, DM Olsen, GH Wheatley, et al.

Endoluminal stent-graft stabiliza tion for thoracic aortic dissection.

J Endovasc Ther, 12 (2005), pp. 354-359

http://dx.doi.org/10.1583/04-1529.1 | Medline

[10]

U Alpagut, M Ugurlucan, E Kafali, B Surmen, OA Sayin, K Guven, et al.

Endoluminal stenting of mycotic saccular aneurysm at the aortic arch.

Tex Heart Inst J, 33 (2006), pp. 371-375

Medline

[11]

MS Makaroun, ED Dillavou, ST Kee, G Sicard, E Chaikof, J Bavaria, et al.

Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis.

J Vasc Surg, 41 (2005), pp. 1-9

http://dx.doi.org/10.1016/j.jvs.2004.10.046 | Medline

[12]

Diethrich, HE Garrett, J Ameriso, ES Crawford, M el-Batyar, ME De-Bakey.

Occlusive disease of the common carotid and subclavian arteries treated by carotid-subclavian bypass. Analysis of 125 cases.

Am J Surg, 114 (1967), pp. 800-808

Medline

[13]

GC Cloud, HS Markus.

Diagnosis and management of vertebral artery stenosis.

QJM, 96 (2003), pp. 27-54

Medline

[14]

TC Rehders, M Petzsch, H Ince, S Kische, T Korber, DH Koschyk, et al.

Intentional occlusion of the left subclavian artery during stent-graft implantation in the thoracic aorta: risk and relevance.

J Endovasc Ther, 11 (2004), pp. 659-666

http://dx.doi.org/10.1583/04-1311R.1 | Medline

[15]

R Scharrer-Pamler, T Kotsis, X Kapfer, J Gorich, KH Orend, L Sunder-Plassmann.

Complications after endovascular treatment of thoracic aortic aneurysms.

J Endovasc Ther, 10 (2003), pp. 711-718

http://dx.doi.org/10.1583/1545-1550(2003)010<0711:CAETOT>2.0.CO;2 | Medline

[16]

K Tiesenhausen, KA Hausegger, P Oberwalder, E Mahla, M Tomka, T Allmayer, et al.

Left subclavian artery management in endovascular repair of thoracic aortic aneurysms and aortic dissections.

J Card Surg, 18 (2003), pp. 429-435

Medline

[17]

KD Calligaro, FJ Veith.

Diagnosis and management of infected prosthetic grafts.

Surgery, 110 (1991), pp. 805-813

Medline

[18]

R Parsons, L Sánchez, M Marín, K Holbrook, P Faries, W Suggs, et al.

Comparison of endovascular and conventional vascular prosthe ses in an experimental infection model.

J Vasc Surg, 24 (1996), pp. 920-926

Medline

[19]

KJ Geary, ZM Tomkiewicz, HN Harrison, WM Fiore, JE Geary, RM Green, et al.

Differential effects of a gram-negative and gram-positive infection on autogenous and prosthetic grafts.

J Vasc Surg, 11 (1990), pp. 339-347

Medline

[20]

SS Rayan, JD Vega, JS Shanewise, LS Kong, EL Chaikof, R Milner.

Repair of mycotic aortic pseudoaneurysm with a stent graft using transesophageal echocardiography.

J Vasc Surg, 40 (2004), pp. 567-570

http://dx.doi.org/10.1016/j.jvs.2004.04.022 | Medline

Tools

Indexed in:

Follow us:

Subscribe:

Subscribe to our newsletter